Reply to Horita and Takeshi: Thrombomodulin Did Not Benefit Acute Exacerbation of Idiopathic Pulmonary Fibrosis in a Trial

Detalles Bibliográficos
Autores principales: Kondoh, Yasuhiro, Azuma, Arata, Tagawa, Jun, Homma, Sakae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Thoracic Society 2020
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328334/
https://www.ncbi.nlm.nih.gov/pubmed/32228231
http://dx.doi.org/10.1164/rccm.202003-0666LE
_version_ 1783552715322818560
author Kondoh, Yasuhiro
Azuma, Arata
Tagawa, Jun
Homma, Sakae
author_facet Kondoh, Yasuhiro
Azuma, Arata
Tagawa, Jun
Homma, Sakae
author_sort Kondoh, Yasuhiro
collection PubMed
description
format Online
Article
Text
id pubmed-7328334
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Thoracic Society
record_format MEDLINE/PubMed
spelling pubmed-73283342020-07-01 Reply to Horita and Takeshi: Thrombomodulin Did Not Benefit Acute Exacerbation of Idiopathic Pulmonary Fibrosis in a Trial Kondoh, Yasuhiro Azuma, Arata Tagawa, Jun Homma, Sakae Am J Respir Crit Care Med Correspondence American Thoracic Society 2020-07-01 2020-07-01 /pmc/articles/PMC7328334/ /pubmed/32228231 http://dx.doi.org/10.1164/rccm.202003-0666LE Text en Copyright © 2020 by the American Thoracic Society https://creativecommons.org/licenses/by-nc-nd/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ). For commercial usage and reprints, please contact Diane Gern (dgern@thoracic.org).
spellingShingle Correspondence
Kondoh, Yasuhiro
Azuma, Arata
Tagawa, Jun
Homma, Sakae
Reply to Horita and Takeshi: Thrombomodulin Did Not Benefit Acute Exacerbation of Idiopathic Pulmonary Fibrosis in a Trial
title Reply to Horita and Takeshi: Thrombomodulin Did Not Benefit Acute Exacerbation of Idiopathic Pulmonary Fibrosis in a Trial
title_full Reply to Horita and Takeshi: Thrombomodulin Did Not Benefit Acute Exacerbation of Idiopathic Pulmonary Fibrosis in a Trial
title_fullStr Reply to Horita and Takeshi: Thrombomodulin Did Not Benefit Acute Exacerbation of Idiopathic Pulmonary Fibrosis in a Trial
title_full_unstemmed Reply to Horita and Takeshi: Thrombomodulin Did Not Benefit Acute Exacerbation of Idiopathic Pulmonary Fibrosis in a Trial
title_short Reply to Horita and Takeshi: Thrombomodulin Did Not Benefit Acute Exacerbation of Idiopathic Pulmonary Fibrosis in a Trial
title_sort reply to horita and takeshi: thrombomodulin did not benefit acute exacerbation of idiopathic pulmonary fibrosis in a trial
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328334/
https://www.ncbi.nlm.nih.gov/pubmed/32228231
http://dx.doi.org/10.1164/rccm.202003-0666LE
work_keys_str_mv AT kondohyasuhiro replytohoritaandtakeshithrombomodulindidnotbenefitacuteexacerbationofidiopathicpulmonaryfibrosisinatrial
AT azumaarata replytohoritaandtakeshithrombomodulindidnotbenefitacuteexacerbationofidiopathicpulmonaryfibrosisinatrial
AT tagawajun replytohoritaandtakeshithrombomodulindidnotbenefitacuteexacerbationofidiopathicpulmonaryfibrosisinatrial
AT hommasakae replytohoritaandtakeshithrombomodulindidnotbenefitacuteexacerbationofidiopathicpulmonaryfibrosisinatrial

Ejemplares similares